Pittsburgh, PA, United States of America

D Lansing Taylor

This inventor holds 23 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 1 EPO patent, primarily in Tissue Imaging Analysis. Top assignees: Cellomics, Inc., Carnegie Mellon University, University of Pittsburgh. Active years: 1986-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: D Lansing Taylor. Retrieved from https://idiyas.com/inventor/d-lansing-taylor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 23 (Patent Applications = 3)

% Patents Active = 91.3

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 2.3

ph-index = 13

Forward Citations = 1,172(Granted Patents)

Location History:

Pittsburg, PA (US) (2003)
Pittsburgh, PA (US) (1986 - 2022)

Company Filing History:

Carnegie Mellon University

patents

3 out of 1,972

University of Pittsburgh

5. 2 out of 834,708

Other

patents

where one patent can have more than one assignee

Years Active: 1986-2026

Loading Chart...

Areas of Expertise:

Tissue Imaging

Cell-Based Screening

Microphysiology

Automated Analysis

Fluorescence Imaging

Spatial Heterogeneity

Liver Acinus Model

Standing Wave Microscopy

Macromolecule Distribution

Multiplexed Imaging

Cell Array Methods

Optical Subsectioning

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12749177 - Systems and methods for finding regions of interest in hematoxylin and eosin (HandE) stained tissue images and quantifying intratumor cellular spatial heterogeneity in multiplexed/hyperplexed fluorescence tissue images (2026-09-29),

2. 12129492 - Human liver microphysiology platform and self assembly liver acinus model and methods of their use (2024-10-29),

3. 11376441 - Systems and methods for finding regions of in interest in hematoxylin and eosin (HandE) stained tissue images and quantifying intratumor cellular spatial heterogeneity in multiplexed/hyperplexed fluorescence tissue (2022-07-05),

4. 11060067 - Human liver microphysiology platform and self assembly liver acinus model and methods of their use (2021-07-13),

5. 10755138 - Systems and methods for finding regions of interest in hematoxylin and eosin (H and E) stained tissue images and quantifying intratumor cellular spatial heterogeneity in multiplexed/hyperplexed fluorescence tissue images (2020-08-25),

6. 8597899 - Method for automated tissue analysis (2013-12-03),

7. 8114615 - Method for automated tissue analysis (2012-02-14),

8. 7853409 - System for cell-based screening (2010-12-14),

9. 7565247 - Method for acquisition, storage, and retrieval of cell screening data on a computer system (2009-07-21),

10. 7235373 - System for cell-based screening (2007-06-26),

11. 7117098 - Machine-readable storage medium for analyzing distribution of macromolecules between the cell membrane and the cell cytoplasm (2006-10-03),

12. 7060445 - System for cell-based screening (2006-06-13),

13. 6902883 - System for cell-based screening (2005-06-07),

14. 6727071 - System for cell-based screening (2004-04-27),

15. 6671624 - Machine readable storage media for detecting distribution of macromolecules between nucleus and cytoplasm in cells (2003-12-30),

Title: The Innovative Journey of D Lansing Taylor

Introduction: D Lansing Taylor, a pioneering inventor hailing from Pittsburgh, PA, has made significant contributions to the field of biotechnology and pharmaceuticals through his groundbreaking innovations.

Latest Patents: Taylor's latest patents focus on novel drug delivery systems that aim to enhance the efficacy and safety of pharmaceutical treatments. These patents showcase his commitment to pushing the boundaries of medical technology.

Career Highlights: With a distinguished career spanning several decades, D Lansing Taylor has held key positions in leading research institutions and biotech companies. His expertise in drug development and biopharmaceuticals has led to the successful commercialization of several life-saving medications.

Collaborations: Throughout his career, Taylor has collaborated with top researchers, scientists, and pharmaceutical companies to drive innovation in the healthcare industry. His collaborative efforts have resulted in the development of cutting-edge therapies for various diseases.

Conclusion: D Lansing Taylor's relentless pursuit of innovation and his passion for improving healthcare have solidified his reputation as a visionary inventor in the field of biotechnology. His contributions continue to inspire the next generation of inventors and researchers.

Profile summary based on public USPTO records.